Pneumonia prevention

AstraZeneca tosses rights to pneumonia prevention drugs for $ 11 million upfront, but keeps tabs on the game

AstraZeneca offloads pneumonia prevention drug to Aridis Pharmaceuticals through worldwide license agreement, which will net Big Pharma $ 11 million in cash and another $ 115 million down the line. Usually these deals go the other way, with a large company taking over the rights to a smaller biotech candidate, but in this case the […]